Results 11 to 20 of about 5,459 (278)

Counterfeit anti-infective drugs [PDF]

open access: yesThe Lancet Infectious Diseases, 2006
The production of counterfeit or substandard anti-infective drugs is a widespread and under-recognised problem that contributes to morbidity, mortality, and drug resistance, and leads to spurious reporting of resistance and toxicity and loss of confidence in health-care systems.
Newton, P   +4 more
openaire   +3 more sources

Faking it - I The Menace of Counterfeit Drugs. [PDF]

open access: yesIndian J Psychiatry, 2008
Byline: G. Swaminath True Lies In a blow to the revenues of India's largest pharmaceutical manufacturer and one of the world's leading generic companies, the United States Food and Drug Administration (FDA) has blacklisted about 30 generic drugs being manufactured by the company at two of their manufacturing sites, citing failure to adhere to current ...
Swaminath G.
europepmc   +3 more sources

Perception of falsified and counterfeit medicines among adults living in Mexico City and the metropolitan area: an underappreciated health risk [PDF]

open access: yesFrontiers in Pharmacology
Falsified and counterfeit medicines represent a growing global public health concern and straddles business implications, and their proliferation has intensified worldwide.
Jessica Citlalli Celaya Pérez   +7 more
doaj   +2 more sources

Counterfeit drugs as a global threat to health [PDF]

open access: yesMedicinski pregled, 2011
According to the World Health Organization, counterfeit medicines are medicines that are mislabeled deliberately and fraudulently regarding their identity and/or source. All kinds of medicines have been counterfeited, both branded and generic ones.
Svetlana Golocorbin-Kon, Momir Mikov
openaire   +4 more sources

Forensic analysis of counterfeit psychotropic drugs [PDF]

open access: yesTalanta Open
Medicine counterfeiting is a worldwide problem affecting all therapeutic areas. The analysis of such products is sometimes a scientific challenge, since their chemical composition is unknown and might be very different from the one of the original ...
Klara Dégardin   +6 more
doaj   +2 more sources

Quality of antidiabetic medicines in 13 sub-Saharan African countries: a cross-sectional surveyResearch in context [PDF]

open access: yesEClinicalMedicine
Summary: Background: The burden of diabetes is rising dramatically in low- and middle-income countries. The menace of substandard and falsified drugs constitutes a major hazard that compromises healthcare.
Marie Antignac   +23 more
doaj   +2 more sources

Dangerous medicines: Unproven AIDS cures and counterfeit antiretroviral drugs [PDF]

open access: yesGlobalization and Health, 2008
Background Increasing access to antiretroviral therapy (ART) is a critical goal endorsed by the United Nations and all of its member states. At the same time, anecdotal accounts suggest that the promotion of unproven AIDS 'cures' and remedies are ...
Amon Joseph J
doaj   +2 more sources

Counterfeit medicines and the unregulated market for drugs [PDF]

open access: yesInternational Psychiatry, 2008
The unregulated market for medicines has evolved in different ways and exists in different forms in different parts of the world. Given this wide variation, the phrase ‘unregulated market for drugs’ is commonly used in a generic sense and encompasses the sale of medicines that have been licitly manufactured but diverted from legitimate sales routes as ...
Hamid Ghodse
openaire   +4 more sources

Counterfeit formulations: analytical perspective on anorectics [PDF]

open access: yes, 2021
Purpose: This paper examines the scope of anorectics in counterfeit weight-reducing formulations and provides insight into the present state of research in determining such adulterants.
Afoakwah, Constance   +2 more
core   +1 more source

Health Care Providers’ Knowledge, Attitude and Practice Toward Counterfeit Medicines in Mizan-Tepi University Teaching Hospital, South West Ethiopia: A Cross-Sectional Study

open access: yesInquiry: The Journal of Health Care Organization, Provision, and Financing, 2022
There is a paucity of evidence-based information regarding healthcare professionals’ awareness and views toward counterfeit medicines in developing countries.
Jafer Siraj BPharm, MSc   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy